Risperidone monotherapy in manic inpatients: an open label, multicentre trial (Q42631462)

4 November 2017

title

Risperidone monotherapy in manic inpatients: an open label, multicentre trial (English)

1 reference

multicenter clinical trial

4 November 2017

main subject

0 references

1 reference

1 reference

4 November 2017

1 reference

4 November 2017

1 reference

4 November 2017

Sandra Dittmann

1 reference

4 November 2017

Anna Forsthoff

1 reference

4 November 2017

Robert Stampfer

1 reference

4 November 2017

Folkhart Schmidt

1 reference

4 November 2017

Martin Schäfer

1 reference

4 November 2017

Leo Hermle

1 reference

4 November 2017

Jörg Walden

1 reference

4 November 2017

Andreas Schreiner

1 reference

4 November 2017

publication date

1 January 2007

1 reference

World Journal of Biological Psychiatry

4 November 2017

published in

1 reference

4 November 2017

1 reference

4 November 2017

1 reference

4 November 2017

page(s)

256-261

1 reference

Clinical Factors in Lithium Carbonate Prophylaxis Failure

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

Risperidone treatment of bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

Tardive dyskinesia with risperidone and anticholinergics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970601169766

10.1080/15622970601169766

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference